MedTrace Logo

Intravenous Fluid for Pediatric Migraine in the Emergency Department

NCT01073787 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-02-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of intravenous fluid (0.9% sodium chloride and water) alone on headache pain in children with migraine visiting the Emergency Department.

Conditions

Interventions

DRUG

Normal saline

10 ml/kg of normal saline will be administered over 30 minutes

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Lawrence P Richer, MD, MSc · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073787 on ClinicalTrials.gov